Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Munoz Carlos Maria RenefiledCriticalMunoz Carlos Maria Rene
Priority to ARP080104865priorityCriticalpatent/AR069217A1/en
Publication of AR069217A1publicationCriticalpatent/AR069217A1/en
Agricultural Chemicals And Associated Chemicals
(AREA)
Abstract
La formulacion comprende metilsoyato y extracto de cuasia amara, incluyendo hasta un 98% de metilsoyato.The formulation comprises methylsoyato and quasia amara extract, including up to 98% methylsoyato.
Use of compound genz-112638 (eliglustat), glucosylceramide synthase inhibitor, in the treatment of gaucher disease and fabry disease (divisional application 201201348).